Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $272.50 million. The enterprise value is $334.81 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 65.82 million shares outstanding. The number of shares has increased by 36.93% in one year.
| Current Share Class | 65.81M |
| Shares Outstanding | 65.82M |
| Shares Change (YoY) | +36.93% |
| Shares Change (QoQ) | +67.60% |
| Owned by Insiders (%) | 6.87% |
| Owned by Institutions (%) | 15.10% |
| Float | 36.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.84 |
| Forward PS | 3.09 |
| PB Ratio | 7.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 2.09.
| Current Ratio | 2.44 |
| Quick Ratio | 1.90 |
| Debt / Equity | 2.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.12 |
Financial Efficiency
Return on equity (ROE) is -144.50% and return on invested capital (ROIC) is -22.45%.
| Return on Equity (ROE) | -144.50% |
| Return on Assets (ROA) | -19.38% |
| Return on Invested Capital (ROIC) | -22.45% |
| Return on Capital Employed (ROCE) | -32.54% |
| Revenue Per Employee | $124,927 |
| Profits Per Employee | -$67,751 |
| Employee Count | 716 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 5.95 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.94% in the last 52 weeks. The beta is 1.92, so Neuronetics's price volatility has been higher than the market average.
| Beta (5Y) | 1.92 |
| 52-Week Price Change | +64.94% |
| 50-Day Moving Average | 4.30 |
| 200-Day Moving Average | 2.28 |
| Relative Strength Index (RSI) | 46.37 |
| Average Volume (20 Days) | 827,350 |
Short Selling Information
The latest short interest is 3.66 million, so 5.57% of the outstanding shares have been sold short.
| Short Interest | 3.66M |
| Short Previous Month | 3.44M |
| Short % of Shares Out | 5.57% |
| Short % of Float | 10.03% |
| Short Ratio (days to cover) | 4.06 |
Income Statement
In the last 12 months, Neuronetics had revenue of $89.45 million and -$48.51 million in losses. Loss per share was -$1.22.
| Revenue | 89.45M |
| Gross Profit | 57.41M |
| Operating Income | -38.12M |
| Pretax Income | -27.54M |
| Net Income | -48.51M |
| EBITDA | -35.78M |
| EBIT | -38.12M |
| Loss Per Share | -$1.22 |
Full Income StatementBalance Sheet
The company has $20.22 million in cash and $82.54 million in debt, giving a net cash position of -$62.31 million or -$0.95 per share.
| Cash & Cash Equivalents | 20.22M |
| Total Debt | 82.54M |
| Net Cash | -62.31M |
| Net Cash Per Share | -$0.95 |
| Equity (Book Value) | 39.53M |
| Book Value Per Share | 0.54 |
| Working Capital | 35.83M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$35.98 million and capital expenditures -$1.31 million, giving a free cash flow of -$37.29 million.
| Operating Cash Flow | -35.98M |
| Capital Expenditures | -1.31M |
| Free Cash Flow | -37.29M |
| FCF Per Share | -$0.57 |
Full Cash Flow StatementMargins
Gross margin is 64.18%, with operating and profit margins of -42.61% and -54.23%.
| Gross Margin | 64.18% |
| Operating Margin | -42.61% |
| Pretax Margin | -54.27% |
| Profit Margin | -54.23% |
| EBITDA Margin | -40.01% |
| EBIT Margin | -42.61% |
| FCF Margin | n/a |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.93% |
| Shareholder Yield | -36.93% |
| Earnings Yield | -17.80% |
| FCF Yield | -13.68% |
Analyst Forecast
The average price target for Neuronetics is $6.00, which is 44.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 44.93% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 29.09% |
| EPS Growth Forecast (5Y) | -65.11% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -3.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.66 |
| Piotroski F-Score | 3 |